Nephrology & Urology Clinical Trials

Statistical methods in nephrology & urology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All nephrology & urology trials

321 results

• A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1): Complete Statistical AnalysisIndependent statistical analysis of A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 119NCT02951767
• A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): Complete Statistical AnalysisIndependent statistical analysis of A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 61NCT03472560
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator’s Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for…Phase 3Results postedn = 623NCT03729245
• A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 5NCT03703908
• A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.: Complete Statistical AnalysisIndependent statistical analysis of A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 210NCT00758602
• A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.: Complete Statistical AnalysisIndependent statistical analysis of A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 52NCT00425438
• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy: Complete Statistical AnalysisIndependent statistical analysis of A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 221NCT03149003
• A Study of LY2928057 in Hemodialysis Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2928057 in Hemodialysis Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01991483).Phase 1Results postedn = 28NCT01991483
• A Study of LY3113593 in Participants With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3113593 in Participants With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02604160).Phase 1Results postedn = 7NCT02604160
• A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011): Complete Statistical AnalysisIndependent statistical analysis of A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 14NCT05656040
• A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002): Complete Statistical AnalysisIndependent statistical analysis of A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 7NCT00968617
• A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 1/2Results postedn = 21NCT04957290
• A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045): Complete Statistical AnalysisIndependent statistical analysis of A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 542NCT02256436
• A Study of Pertuzumab in Participants With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Pertuzumab in Participants With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02480010).Phase 2Results postedn = 68NCT02480010
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems: Complete Statistical AnalysisIndependent statistical analysis of A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1Results postedn = 17NCT03814005
• A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 39NCT00515697
• A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 95NCT03294083
• A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 52NCT01981122
• A Study of Tadalafil in Benign Prostatic Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of A Study of Tadalafil in Benign Prostatic Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183650).Phase 1Results postedn = 24NCT01183650
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of A Study of Tadalafil in Men With Benign Prostatic Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00970632).Phase 3Results postedn = 511NCT00970632
• A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms: Complete Statistical AnalysisIndependent statistical analysis of A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 696NCT01139762
• A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 116NCT02085252
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 507NCT01098539
• A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 48NCT04424641
• A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function: Complete Statistical AnalysisIndependent statistical analysis of A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function: primary endpoint results, effect estimate with confidence…Phase 2Results postedn = 397NCT00478881
• A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax): Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 11NCT02576145
• A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.: Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.: primary endpoint results, effect…Phase 2Results postedn = 16NCT00678288
• A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart: Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 24NCT04256629
• A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 84NCT04190446
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD): primary endpoint…Phase 3Results postedn = 2NCT04064827
• A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor: primary endpoint results,…Phase 2Results postedn = 150NCT01974206
• A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 25NCT03116685
• A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces: Complete Statistical AnalysisIndependent statistical analysis of A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces: primary endpoint results, effect estimate…Phase NAResults postedn = 2,313NCT06151418
• A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC): Complete Statistical AnalysisIndependent statistical analysis of A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 3,017NCT06072196
• A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease: primary endpoint results,…Phase 2Results postedn = 714NCT05182840
• A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1/2Results postedn = 1NCT03498196
• A-PREDICTIndependent statistical analysis of A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 65NCT01693822
• AASKA statistical analysis of the AASK phase 3 trial evaluating blood pressure targets and antihypertensive strategies in African American patients with hypertensive nephrosclerosis and chronic renal insufficiency.Phase 3n = 1,094NCT04364139
• ABEMA Alone or in COMBO With MK-6482: Complete Statistical AnalysisIndependent statistical analysis of ABEMA Alone or in COMBO With MK-6482: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04627064).Phase 1Results postedn = 11NCT04627064
• Active and Passive Music Therapy Interventions: Complete Statistical AnalysisIndependent statistical analysis of Active and Passive Music Therapy Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03362944).Phase NAResults postedn = 16NCT03362944
• Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 22NCT02232282
• Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda: Complete Statistical AnalysisIndependent statistical analysis of Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 440NCT00405821
• Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer:…Phase NAResults postedn = 28NCT05628363
• Afatinib in Subjects With Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Afatinib in Subjects With Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096718).Phase 1Results postedn = 30NCT02096718
• AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 12NCT05375539
• AiME – 13Independent statistical analysis of A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance…Phase 3Results postedn = 320NCT01473420
• AKIKIIndependent statistical analysis of AKIKI (NCT01932190), a randomized trial comparing early and delayed renal replacement therapy strategies in intensive care patients with acute kidney injury.Phase NAn = 620NCT01932190
• Alkali Therapy in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Alkali Therapy in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01452412).Phase 2/3Results postedn = 149NCT01452412
• AMILORIndependent statistical analysis of Amiloride in Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05079789).Phase 3Results postedn = 20NCT05079789
• An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 101NCT01574326

← All therapeutic areas